Magnolia Medical Technologies Inc.
Patent owner in reexamination·6 ex parte reexams
Magnolia Medical Technologies Inc.'s patents have been the subject of 6 USPTO ex parte reexaminations, with 5 currently open. Its patents are most often challenged by Kurin Inc.. ExamPat indexes the full prosecution record for each proceeding, including office-action grounds, certificate outcomes, and downstream PTAB and Federal Circuit decisions.
Filings by year
Top requesters
Outcome track record
How reexams of this owner's patents resolve: claims confirmed, amended, mixed, or fully canceled.
- Certificate outcome split across every bucket
- Claim-survival rate
Defense metrics
Claim-survival rate, average pendency, and the open/closed split across every reexam of this owner's patents.
- Survival rate of closed proceedings
- Average pendency in months
Challengers & examiners
Which requesters most often challenge this owner's patents, and which examiners decide them.
- Top requesters
- Most frequent examiners
Recent reexaminations (6)
| Control # | Filed | Patent | Title | Requester | Status |
|---|---|---|---|---|---|
| 90/015,399 | Jul 21, 2025 | 10,039,483 | FLUID DIVERSION MECHANISM FOR BODILY-FLUID SAMPLING | — | Open |
| 90/019,823 | Jan 21, 2025 | 11,529,081 | FLUID CONTROL DEVICES AND METHODS OF USING THE SAME | — | Open |
| 90/019,824 | Jan 21, 2025 | 11,903,709 | FLUID CONTROL DEVICES AND METHODS OF USING THE SAME | — | Open |
| 90/019,825 | Jan 21, 2025 | 11,653,863 | FLUID CONTROL DEVICES AND METHODS OF USING THE SAME | Kurin Inc. | Open |
| 90/019,756 | Dec 6, 2024 | 10,052,053 | SYSTEMS AND METHODS FOR PARENTERALLY PROCURING BODILY-FLUID SAMPLES WITH REDUCED CONTAMINATION | — | Closed |
| 90/019,177 | Mar 22, 2023 | 10,039,483 | FLUID DIVERSION MECHANISM FOR BODILY-FLUID SAMPLING | — | Open |
See the full reexam picture for Magnolia Medical Technologies Inc.
Certificate outcomes, pendency, and the parties and examiners behind these cases. Free to sign up.